Mark Walchirk of McKesson joins executive board
At its annual board and membership meeting, the Healthcare Distribution Management Assn. announced the reelection of David Neu, president of AmerisourceBergen Drug Corp., as its chairman, and Ted Scherr, CEO of Dakota Drug, as vice chairman.
Mark Walchirk, president of McKesson US Pharmaceutical, was elected to replace Paul Julien, also of McKesson, as board member and member of the executive committee of HDMA.
Other executive committee members are: Ken Couch, president of Smith Drug Co., Michael Kaufmann, CEO of the Pharmaceutical Segment of Cardinal Health, David Moody, CEO of Mutual Wholesale Drug Co., Dale Smith, chairman of H.D. Smith, and John Gray, president of HDMA.
Mary Tim Smith, CFO of R&S Northeast LLC, was elected as a board member to replace Greg Duche, CEO of R&S Northeast.
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.